The goal of identifying a set of pretreatment risk-stratifying factors for patients with localized prostate cancer is to be able to individualize treatment and optimize patient selection for clinical trials. Low-risk patients are most likely
Michael E. Ray, MD, PhD
Advertisement
Articles by Michael E. Ray, MD, PhD
Advertisement
Latest Updated Articles
- Combined-Modality Staging for Localized Adenocarcinoma of the Prostate
Published: August 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma
3
Real-World Data From IMS: Promising Results in Relapsed/Refractory Multiple Myeloma
4
Leveraging Novel Software to Further Improve Personalized Cancer Care
5
